107 related articles for article (PubMed ID: 2760481)
21. Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.
Bishop AL; Tarique AA; Patimalla B; Calderwood SB; Qadri F; Camilli A
J Infect Dis; 2012 Feb; 205(3):412-21. PubMed ID: 22147790
[TBL] [Abstract][Full Text] [Related]
22. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.
Schild S; Nelson EJ; Camilli A
Infect Immun; 2008 Oct; 76(10):4554-63. PubMed ID: 18678672
[TBL] [Abstract][Full Text] [Related]
23. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.
Leitner DR; Feichter S; Schild-Prüfert K; Rechberger GN; Reidl J; Schild S
Infect Immun; 2013 Jul; 81(7):2379-93. PubMed ID: 23630951
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of different subcellular fractions of Vibrio cholerae O139 in protection to challenge in experimental cholera.
Bondre VP; Sinha VB; Srivastava BS
FEMS Immunol Med Microbiol; 1997 Dec; 19(4):323-9. PubMed ID: 9537758
[TBL] [Abstract][Full Text] [Related]
26. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
27. Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.
Boesman-Finkelstein M; Walton NE; Finkelstein RA
Infect Immun; 1989 Apr; 57(4):1227-34. PubMed ID: 2925248
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions.
Adriani R; Mousavi Gargari SL; Nazarian S; Sarvary S; Noroozi N
Vaccine; 2018 Jan; 36(2):322-330. PubMed ID: 29191736
[TBL] [Abstract][Full Text] [Related]
29. Production and characterization of monoclonal antibodies to Vibrio cholerae soluble haemagglutinin.
Wikström M; Jonsson G; Svennerholm AM
APMIS; 1991 Mar; 99(3):249-56. PubMed ID: 2018638
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
Attridge SR; Rowley D
J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
[TBL] [Abstract][Full Text] [Related]
31. Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal.
Qadri F; Azim T; Chowdhury A; Hossain J; Sack RB; Albert MJ
Clin Diagn Lab Immunol; 1994 Jan; 1(1):51-4. PubMed ID: 7496922
[TBL] [Abstract][Full Text] [Related]
32. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili.
Eko FO; Mayr UB; Attridge SR; Lubitz W
J Biotechnol; 2000 Sep; 83(1-2):115-23. PubMed ID: 11000467
[TBL] [Abstract][Full Text] [Related]
33. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.
Winner L; Mack J; Weltzin R; Mekalanos JJ; Kraehenbuhl JP; Neutra MR
Infect Immun; 1991 Mar; 59(3):977-82. PubMed ID: 1705246
[TBL] [Abstract][Full Text] [Related]
34. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model.
Sun DX; Mekalanos JJ; Taylor RK
J Infect Dis; 1990 Jun; 161(6):1231-6. PubMed ID: 1971653
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity.
Sinha R; Howlader DR; Ta A; Mitra S; Das S; Koley H
Vaccine; 2017 Jun; 35(28):3534-3547. PubMed ID: 28545924
[TBL] [Abstract][Full Text] [Related]
36. Pentavalent outer membrane vesicles of Vibrio cholerae induce adaptive immune response and protective efficacy in both adult and passive suckling mice models.
Sinha R; Koley H; Nag D; Mitra S; Mukhopadhyay AK; Chattopadhyay B
Microbes Infect; 2015 Mar; 17(3):215-27. PubMed ID: 25461799
[TBL] [Abstract][Full Text] [Related]
37. Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139.
Pal S; Sasmal D; Guhathakurta B; Nair GB; Bhattacharya SK; Mallick R; Datta A
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):143-8. PubMed ID: 8880140
[TBL] [Abstract][Full Text] [Related]
38. Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella.
Jacques I; Cloeckaert A; Limet JN; Dubray G
J Med Microbiol; 1992 Aug; 37(2):100-3. PubMed ID: 1378499
[TBL] [Abstract][Full Text] [Related]
39. Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae.
Falero G; Rodríguez BL; Rodríguez I; Campos J; Ledon T; Valle E; Silva Y; Marrero K; Suzarte E; Valmaseda T; Moreno A; Fando R
Hybrid Hybridomics; 2003 Oct; 22(5):315-20. PubMed ID: 14678649
[TBL] [Abstract][Full Text] [Related]
40. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity.
Vakili A; Mousavi Gargari SL; Nazarian S; Amani J
Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
